EXTON, Pa., March 13 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, chief financial officer and chief operating officer of ViroPharma, will present at the Cowen & Company 28th Annual Health Care Conference at 1:40 P.M. ET on Tuesday, March 18, 2008. The conference is being held at the Boston Marriott Copley Place.
ViroPharma's presentation will be webcast live for investors through www.viropharma.com and available through April 1, 2008.
About ViroPharma Incorporated
ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin®, approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the company's website at www.viropharma.com.
SOURCE ViroPharma Incorporated 03/13/2008
CONTACT: William C. Roberts, Vice President, Corporate Communications,
+1-610-321-6288, or Robert A. Doody, Manager, Corporate Communications,
+1-610-321-6290, both of ViroPharma Incorporated
Web site: http://www.viropharma.com